150 related articles for article (PubMed ID: 36695734)
21. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
22. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
23. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
24. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
25. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
[TBL] [Abstract][Full Text] [Related]
26. Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs.
Cevallos RR; Edwards YJK; Parant JM; Yoder BK; Hu K
Sci Rep; 2020 Nov; 10(1):19710. PubMed ID: 33184372
[TBL] [Abstract][Full Text] [Related]
27. Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective.
Huyghe A; Trajkova A; Lavial F
Trends Cell Biol; 2024 Mar; 34(3):255-267. PubMed ID: 37648593
[TBL] [Abstract][Full Text] [Related]
28. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
[TBL] [Abstract][Full Text] [Related]
29. Facile and efficient reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.
Ni A; Wu MJ; Nakanishi Y; Chavala SH
Stem Cells Dev; 2013 Sep; 22(18):2543-50. PubMed ID: 23635313
[TBL] [Abstract][Full Text] [Related]
30. Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation.
Tahmasebi S; Ghorbani M; Savage P; Yan K; Gocevski G; Xiao L; You L; Yang XJ
J Biol Chem; 2013 May; 288(18):12791-804. PubMed ID: 23515309
[TBL] [Abstract][Full Text] [Related]
31. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
32. Biological importance of OCT transcription factors in reprogramming and development.
Kim KP; Han DW; Kim J; Schöler HR
Exp Mol Med; 2021 Jun; 53(6):1018-1028. PubMed ID: 34117345
[TBL] [Abstract][Full Text] [Related]
33. Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.
Sui D; Sun Z; Xu C; Wu Y; Capecchi MR; Wu S; Li N
Stem Cell Reports; 2014 May; 2(5):721-33. PubMed ID: 24936457
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming.
Moauro A; Ralston A
Methods Mol Biol; 2022; 2429():41-55. PubMed ID: 35507154
[TBL] [Abstract][Full Text] [Related]
35. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
[TBL] [Abstract][Full Text] [Related]
36. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
Cai Y; Dai X; Zhang Q; Dai Z
Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
[TBL] [Abstract][Full Text] [Related]
37. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
39. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
Oh HR; Kim J; Kim J
FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
[TBL] [Abstract][Full Text] [Related]
40. Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells.
Wang Y; Lu T; Sun G; Zheng Y; Yang S; Zhang H; Hao S; Liu Y; Ma S; Zhang H; Ru Y; Gao S; Yen K; Cheng H; Cheng T
Nat Commun; 2019 Dec; 10(1):5594. PubMed ID: 31811153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
